Drugs / TTRNA-DC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06254326 | Sep 2024 → Dec 2027 expected | oligodendroglioma | University of Florida | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TTRNA-DC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06254326 ↗ |
| Modality | Cell therapy | “adoptive cellular therapy” NCT06254326 ↗ |